Pacientes elegibles para las nuevas terapias de la insuficiencia cardíaca en un policlínico especializado
Background: Pharmacological treatment improves survival in patients with heart failure with reduced ejection fraction. The use of sacubutril/valsartan and ivabradine has been recently approved and incorporated in the latest guidelines. Aim: To identify candidates eligible for these therapies among...
Enregistré dans:
| Auteurs principaux: | , , , , , , |
|---|---|
| Langue: | Spanish / Castilian |
| Publié: |
Sociedad Médica de Santiago
2019
|
| Sujets: | |
| Accès en ligne: | http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872019000300330 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|